---
title: Alloy Therapeutics vs Qoolabs, Inc
slug_a: alloytx
slug_b: qoolabs
site: cro
review_signal_gate: closed
canonical_path: /compare/alloytx/qoolabs
---

# Alloy Therapeutics vs Qoolabs, Inc

Side-by-side profile data from each company listing on this directory.

## Alloy Therapeutics

- Profile: [/companies/alloytx](/companies/alloytx)

Alloy Therapeutics — Product development organization offering AI/ML-driven antibody and multispecific discovery, TCR mimic (TCRm) discovery, and antisense oligonucleotide design, backed by transgenic mouse platforms and pharmacology studies.

Services: 5. Modalities: 2. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (5).

### Services

- Discovery Research
- Computational & In-Silico Drug Discovery
- Protein Engineering
- In Vitro Pharmacology
- Preclinical In Vivo Studies

### Modalities

- Biologics (Monoclonal Antibodies)
- Oligonucleotide

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (General)

### Sourcing models

- Data not yet provided.

## Qoolabs, Inc

- Profile: [/companies/qoolabs](/companies/qoolabs)

Qoolabs, Inc — Qoolabs specializes in rapid rabbit monoclonal antibody development using the QMAb™ platform, delivering highly specific antibodies with natural heavy-light chain pairing in 3–4 months from immunization.

Services: 2. Modalities: 1. Indications: 2. Locations: 0. Certifications: 1. The strongest documented coverage currently appears in services (2).

### Services

- Protein Engineering
- Translational Research

### Modalities

- Biologics (Monoclonal Antibodies)

### Indications

- Immunology
- Infectious Disease

### Phases

- Discovery
- Preclinical (General)

### Sourcing models

- Full-Service Outsourcing (FSO)